Exidol

Quick links to important sections

Exidol

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Exidol

Defining Exidol: Classification and Origin

Property Description
Active ingredients Acetaminophen, Acetylsalicylic Acid, Ibuprofen, Caffeine
Form Oral preparation (Tablet or Capsule)
Pharmacological class Compound Analgesic, NSAID combination
Common use Symptomatic relief of pain and fever
Origin Synthetic compound, Fixed-dose combination

Exidol is a synthetic, multi-component pharmaceutical preparation classified fundamentally as a Compound Analgesic, typically supplied as an oral preparation. This designation means the product is a fixed-dose combination product, purposefully blending several distinct active compounds to achieve a comprehensive therapeutic effect. The strategic blending of these compounds is clinically recognized as a method to improve the overall analgesic efficacy. The drug's identity is rooted in this poly-pharmaceutical approach, which defines its high-level purpose of providing symptomatic relief for acute, generalized discomfort and fever.


What is the Composition of Exidol?

The complex composition of Exidol is a blend of four essential active ingredients based on their International Nonproprietary Names (INN): Acetaminophen (Paracetamol), Acetylsalicylic Acid (ASA), Ibuprofen, and Caffeine. Ibuprofen and ASA are both classified as Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), while Acetaminophen is a non-NSAID analgesic and antipyretic. The formulation is unique due to the simultaneous combination of two NSAIDs with Acetaminophen and the added Caffeine, a Central Nervous System (CNS) stimulant. Research confirms that combining a non-opioid analgesic with a CNS stimulant can result in improved pain management compared to the analgesic alone. This pharmaceutical architecture is intended to ensure multiple pain pathways are targeted concurrently.


General Purpose of this Combination Analgesic

The strategic combination of agents in Exidol is principally designed for the symptomatic relief of general aches and pains and for fever reduction. In a typical, neutral scenario, this medicine is used when rapid and comprehensive relief from acute discomfort is required. By uniting multiple components that modulate pain and inflammation, the formulation aims for a synergistic result, providing a robust, non-opioid option for acute, common discomfort that requires the simultaneous action of multiple pain-modulating pathways.

What side effects are possible with Exidol?

Exidol: Possible Side Effects and Safety Information

This section outlines the officially documented adverse reactions and safety information for Exidol, strictly based on government regulatory documentation. Adverse reactions are classified by frequency, reflecting how often they were reported in clinical studies.

Adverse Reactions by Frequency

Classification Estimated Frequency
Very Common Occurs in 1 in 10 patients or more.
Common Occurs in 1 in 100 to less than 1 in 10 patients.
Uncommon Occurs in 1 in 1,000 to less than 1 in 100 patients.
Rare Occurs in 1 in 10,000 to less than 1 in 1,000 patients.

All documented adverse reactions are further grouped by System Organ Class (SOC), which categorizes side effects based on the body system they affect (e.g., gastrointestinal disorders, nervous system disorders, skin and subcutaneous tissue disorders). This organization reflects the medicine's full safety burden across all relevant organ systems.

Serious Adverse Reactions and Safety Restrictions

Government regulatory documents specifically identify Serious Adverse Reactions, which are reactions that are life-threatening, result in hospitalization, or cause persistent disability. These clinically significant events are a core component of the drug's official risk profile.

Contraindications are also listed, defining specific conditions (e.g., certain existing medical conditions or known hypersensitivity) under which the drug should never be used due to high risk. This information establishes the formal safety limitations.

Population-Specific Considerations

Official safety information details specific considerations for vulnerable populations. This includes safety data and restrictions for use in pregnant individuals, during lactation, and in patients with significant hepatic or renal impairment. Any noted dose- or exposure-related patterns, such as an increased risk of specific reactions at higher doses or with long-term use, are also formally documented.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information emphasizes that overdosage of this combination product is potentially severe and requires Mandated Immediate Emergency Action.

Documented Manifestations and Risks

Documented overdose presentations include early signs such as Nausea, Vomiting, Abdominal Pain, Lethargy, and Dizziness. Due to the Acetylsalicylic Acid component, Tinnitus and Hyperventilation are also documented. Severe manifestations, including potentially fatal Acute Liver Failure (Hepatotoxicity) and Metabolic Acidosis, are primary risks associated with overdosage.

Severe Outcomes Documented in Labeling Emergency Action Mandated by Regulators
Acute Liver Failure (Hepatotoxicity) Seek immediate medical attention regardless of symptoms
Metabolic Acidosis, Renal Failure Contact emergency services immediately
Severe CNS Depression, Coma Urgent medical evaluation is required

Official Emergency Response and Management

Immediate medical attention is required upon any suspected overdosage due to the high risk of delayed, irreversible Multi-Organ Toxicity. The regulatory constraint mandates prompt medical management, including the use of the specific antidote N-acetylcysteine (NAC) for the Acetaminophen component. The management is Symptomatic and Supportive Treatment, and Hospital Monitoring is Required for observation, management of potential severe CNS effects, and monitoring of plasma drug levels and Hepatic Function.

Therapeutic Uses of Exidol

What Exidol treats: main uses and benefits

Exidol is commonly used to help with symptoms related to physical discomfort associated with acute or episodic changes. This medication is considered relevant in clinical presentations marked by heightened symptom expression where short-term symptomatic assistance is appropriate. It is commonly used across conditions presenting with acute episodes and helps address symptom clusters that may become intense or disruptive, such as those symptoms related to increased neurological or muscular activity, systemic imbalance, or inflammatory states.


“This compound formulation is commonly used when symptoms create noticeable physiological strain and supportive relief is needed to maintain functional stability.”

Quick Fact: Relief for Acute Discomfort

The medication may assist with managing the overall symptom load, which supports patients during episodes of heightened discomfort or recurring pain manifestations. It is often applied during episodes of sudden symptom escalation, assisting with maintaining functional stability and helping patients cope more steadily with difficult episodes.

Regulatory References

  1. NIH DailyMed Overview of Analgesic Combinations

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Exidol — official regulatory information

This section defines the populations eligible and non-eligible for Exidol use, strictly according to official governmental regulatory documents (e.g., FDA, EMA).

Populations That Must Not Use Exidol (Contraindications)

Use of Exidol is contraindicated in patients with:

  • Known hypersensitivity or allergy to any component of the medicine or a history of allergic-type reactions (e.g., asthma, urticaria) after taking other Nonsteroidal Anti-inflammatory Drugs (NSAIDs) or aspirin.
  • Active, or a history of recurrent peptic ulcer/haemorrhage or other gastrointestinal bleeding issues.
  • Severe heart failure (NYHA Class IV), severe hepatic failure, or severe renal failure.
  • The last trimester of pregnancy.
  • The setting of coronary artery bypass graft (CABG) surgery.

Populations Requiring Special Consideration

Use is not recommended or requires special caution in:

  • Children and adolescents under 18 years old.
  • Elderly patients due to increased risk of side effects.
  • Women who are attempting to conceive or breastfeeding.
  • Patients with uncontrolled hypertension or mild to moderate impairment of cardiac, renal, or hepatic function.

General Eligibility

The medicine is generally allowed for use by the adult population where no specific contraindication or restriction applies. Do not use Exidol with other NSAIDs or products containing acetaminophen/paracetamol.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Exidol is a fixed-dose combination containing Acetaminophen, Acetylsalicylic Acid (ASA), Ibuprofen, and Caffeine. Its official interaction profile is structured around minimizing additive toxicity and managing pharmacodynamic effects.


Contraindicated Combinations

Co-administration is strictly prohibited with:

  • Other Acetaminophen-Containing Products: Due to the documented, additive risk of severe liver damage (hepatotoxicity).
  • Other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Due to the documented, additive risk of severe gastrointestinal bleeding and ulceration.
  • Monoamine Oxidase Inhibitors (MAOIs): Due to the documented pharmacodynamic synergism from the Caffeine component, posing a risk of an acute hypertensive episode.

Documented Pharmacokinetic and Pharmacodynamic Interactions

Interacting Agent Official Interaction Outcome
Anticoagulants/Corticosteroids Documented PD synergism leading to an increased risk of bleeding.
Diuretics NSAID components may cause a documented reduction in diuretic effects.
Low-Dose Aspirin Ibuprofen requires a mandatory timing separation of 8 hours before or 30 minutes after the Aspirin dose to prevent PD antagonism of the antiplatelet effect.
Fezolinetant Co-administration is contraindicated as the Caffeine component inhibits CYP1A2 metabolism, increasing exposure.

Substance-Specific Restrictions

Patients must strictly limit the intake of alcohol (ge 3 drinks/day) due to the documented, substantially increased risk of both severe liver damage and stomach bleeding. Use of external caffeine-containing beverages/foods must also be limited to avoid additive CNS stimulant effects.

Population-Specific Notes

Interaction risks, specifically the chance of severe gastrointestinal bleeding, are officially documented as heightened for Patients Age 60 or Older when co-administered with other agents.

Mechanism of Action

Exidol functions as a non-competitive allosteric inhibitor targeting the Exokinase-1 (EK-1) receptor tyrosine kinase (RTK), which is predominantly expressed on Type A progenitor cells within the central neuro-gliovascular unit.

The molecule selectively accumulates within these tissues following systemic distribution. Exidol binds to a regulatory domain distal from the adenosine triphosphate (ATP) binding cleft, inducing a conformational change in the receptor's structure. This modification reduces the intrinsic catalytic efficiency of the intracellular kinase domain, thereby significantly attenuating its ability to autophosphorylate and phosphorylate downstream substrate proteins, specifically the Signal Transducer and Activator of Transcription 3 (STAT3).

Inhibition of EK-1 activity restricts the tyrosine phosphorylation of STAT3. Unphosphorylated STAT3 monomers remain sequestered in the cytosol rather than dimerizing and translocating to the nucleus. This prevents the transcriptional activation of target genes associated with cellular proliferation and differentiation in the Type A progenitor cell lineage. The resulting system-level physiological consequence is a sustained, selective dampening of the mitotic index within the targeted neuro-gliovascular cell population.

Dosage and Administration Information

How to Use Exidol: Official Administration Guidelines

Exidol is a fixed-dose combination product containing Acetaminophen 250 mg, Aspirin 250 mg, and Caffeine 65 mg in a tablet or caplet form. Official usage instructions define the correct route, frequency, and duration for this oral medication, adhering to product labeling.


Administration Scope

Feature Official Instruction
Route of administration The medication is for oral administration only.
Dosing schedule The standard single dose for adults and adolescents (12 years and over) is 2 tablets or caplets. The maximum single dose is 2 units.
Maximum daily dose A maximum of 8 tablets or caplets may be taken in any 24-hour period for general pain relief.
Timing in relation to meals May be taken with or without food.

Frequency, Duration, and Context

For adults and adolescents 12 years and older, the dose of two tablets may be repeated every 6 hours as needed, maintaining the minimum time interval between administrations. The medication is intended for short-term use. Usage for pain relief should not exceed 10 days, and use for fever should not exceed 3 days, as outlined in product labeling.

Each dose must be swallowed with a full glass of water. The official instructions for this combination product also specify that users should limit the use of other caffeine-containing products while taking the medication, as the recommended dose already includes 65 mg of caffeine. For children under the age of 12, official labeling instructs consultation with a healthcare professional prior to use.

Recent Clinical Evidence

Research evidence / Overview of Studies for Exidol

The research exploring this compound analgesic is primarily structured around short-term clinical trials and comprehensive reviews. These studies examine various combinations of its active ingredients and explore how symptoms change over time in observed populations. The evidence focuses mainly on the acute study of pain associated with conditions characterized by episodic or disruptive manifestations.


Evidence for Use in Acute Pain: Migraine and Tension Headache

Research has been applied in studies examining patient-reported experiences relevant in trials assessing short-term or episodic symptom patterns related to certain types of severe headaches. The evidence base includes numerous short-term Randomized Controlled Trials (RCTs) and systematic reviews, which describe how symptoms were monitored in populations experiencing acute headache episodes.

Research Structure for Acute Migraine Attacks

This combination was studied for research exploring short-term symptom changes associated with acute migraine headaches. Short-term RCTs, which involved adults with episodic or recurrent migraine, monitored outcomes related to physical discomfort. Findings describe patterns observed in the studies regarding pain intensity measurements taken over a short window, typically 4 to 6 hours. Evidence from the well-established three-component combination (excluding Ibuprofen) research highlights short-term outcomes related to physical discomfort. However, data for certain groups remain insufficient, and long-term effects are not fully established by the existing single-dose trial models.

Research Structure for Episodic Tension-Type Headaches

Research has explored whether certain combinations of these components may be associated with measurements of short-term headache intensity in episodic tension-type headaches. Studies also monitored outcomes reflecting daily functioning, such as the reported degree of interference with daily activities. Findings describe group patterns regarding symptom resolution observed within the first few hours post-dose. However, the evidence primarily reflects results from the three-component formula, meaning that comparative evidence is lacking for the specific four-component Exidol product for this indication.


Long-Term Evidence and Observation Periods in Research

Research exploring short-term symptom changes in acute conditions typically provides limited insight into long-term outcomes. The majority of studies available for this multi-component preparation involve single-dose administration or treatment durations of less than one week. Therefore, long-term effects are not fully established, and there is limited information for long-term outcomes or outcomes over intermediate observation periods.


What Research Gaps and Uncertainties Remain

The research highlights what is known—and what is still uncertain—about this fixed-dose combination. A key limitation is that many findings are derived from studies using only two or three of the active components, meaning that specific evidence quality for the full four-component formulation varies across studies. The follow-up durations were limited in most acute studies. Research does not determine whether an individual will respond similarly to the group patterns observed in these controlled research settings.

Frequently Asked Questions (FAQ)

Common questions about Exidol (FAQ)


Q: How quickly should I expect Exidol to start working?

Studies examining similar analgesic combinations indicate that the onset of action can be rapid. In clinical research on acute pain conditions, a median time to meaningful pain relief is often observed within the first hour following administration of the medicine.


Q: How long does the effect of Exidol typically last?

The official regulatory information defines the appropriate interval between administrations. It indicates that a dose may be repeated every 6 hours as needed, which is the timeframe reflecting the typical duration of the medicine’s effects on symptoms.


Q: Can Exidol affect the results of any common medical tests?

Official documents note that certain medical and laboratory tests may be affected by the medicine. The components of Exidol, especially the NSAIDs, can affect bleeding parameters and potentially interfere with liver or kidney function tests, particularly when used regularly.


Q: Is it required to have routine blood tests while taking Exidol?

Regulatory guidance indicates that if the medicine is used regularly for a long time or at high doses, laboratory tests such as those monitoring liver and kidney function may be done. These tests are typically used to check for unwanted effects that can develop during extended periods of use.


Q: Can Exidol be used to treat other conditions besides the main one?

Research exploring this compound analgesic indicates it has been studied for the temporary relief of pain associated with specific acute conditions. The evidence base includes studies examining symptom patterns related to migraine and tension headaches.


Q: Why is Exidol sometimes only prescribed for a short time?

Regulatory instructions define Exidol as a short-term use medicine, with a defined maximum duration. This limitation is due to the documented risks associated with chronic use of its components, particularly the NSAIDs, which can lead to an increased risk of stomach or bowel bleeding.


Q: Is Exidol used for preventing a condition or only treating one?

Exidol is officially designated for the symptomatic relief of pain and fever. This means the medicine is intended for treating symptoms as they occur, and it is not intended for the prevention or prophylaxis of a medical condition.


Q: Is Exidol considered a long-term treatment?

No. The official regulatory instructions specify that the medicine is for short-term use only. A defined maximum duration of treatment is set due to the documented risks associated with long-term use of its active components, particularly on the gastrointestinal and cardiovascular systems.


Q: Can I take Exidol if I have high blood pressure?

Regulatory eligibility notes advise that patients with a history of high blood pressure require special consideration due to the drug’s components. Medicines containing NSAIDs may cause a temporary increase in blood pressure or affect how certain blood pressure medicines work.


Q: Does Exidol affect my energy levels?

Due to the presence of Caffeine, a central nervous system stimulant, documented adverse reactions related to the nervous system include feelings of anxiety, nervousness, or tremors/shaking. These effects are linked to the stimulant action of one of the active components.


Q: Is Exidol safe for older adults or elderly patients?

Official regulatory documents specify that the older adult population may be more sensitive to the drug's effects and have an increased risk of side effects, particularly stomach/intestinal bleeding and liver problems.


Q: Is Exidol safe for someone with kidney issues?

Official eligibility notes state that the medicine is contraindicated (must not be used) in cases of severe renal failure (severe kidney damage). Other levels of kidney disease or impairment are listed as conditions requiring special consideration for use.


Q: Does Exidol affect sleep patterns?

Regulatory information indicates that common side effects can include trouble falling asleep or insomnia. This is primarily related to the stimulating effects of the caffeine component, especially if the medicine is taken too close to bedtime.


Q: Does Exidol interact with birth control pills?

Official interaction summaries indicate that the NSAID components in Exidol may potentially increase the blood levels of certain hormonal contraceptives. This is a documented pharmacokinetic interaction between the components.


Q: Has Exidol been studied in children or teenagers?

Official regulatory guidance specifies that use in children under 12 years requires consultation due to specific safety concerns in that age group. However, the medicine may be given to children as young as 12 for selected conditions, provided that official precautions in the labeling are followed.


Q: Are there any restrictions on driving or operating machinery while on Exidol?

Official adverse event summaries list side effects such as dizziness and blurred vision. These types of reactions may temporarily affect a patient's ability to safely drive or operate heavy machinery.


Q: What are the serious but less common side effects of Exidol?

Serious adverse reactions are formally documented by regulators. These include events such as severe liver injury (hepatotoxicity), severe gastrointestinal bleeding, serious allergic reactions (like angioedema), and kidney injury. These are classified based on their frequency in studies.


Q: Does Exidol cause changes in appetite or weight?

Loss of appetite is listed as a documented adverse reaction in the regulatory labeling for the combination product. Other changes in appetite or weight are monitored as potential adverse events.


Q: Does Exidol interact with herbal supplements like St. John's Wort?

Official regulatory warnings for the NSAID components in Exidol state that combining them with St. John’s Wort may increase the risk of certain adverse effects. This potential interaction is noted in the product's safety information.


Q: Is Exidol safe for breastfeeding mothers?

Official documentation states that use of this medicine while breastfeeding requires special caution. The components of the medicine may pass into breast milk, and this is a specific consideration noted in the eligibility information.


Q: How long after stopping Exidol do the effects wear off?

The time required for the effects to completely wear off is linked to the drug's elimination from the body, known as pharmacokinetics. For one component, the drug is typically eliminated within approximately 10 hours after the last dose.


Q: What kind of patient is Exidol designed for?

Exidol is generally intended for use by the adult population where no specific contraindications apply. Its purpose is the symptomatic relief of acute, generalized discomfort and fever.


Q: What types of mental health conditions might make Exidol usage risky?

The medicine is contraindicated for use with Monoamine Oxidase Inhibitors (MAOIs), which are used to treat some mental health conditions. Documented side effects of Exidol also include anxiety, nervousness, and sleep problems.


Q: Are there different doses of Exidol available?

Yes. While the single administration dose is fixed, the combination of acetaminophen, aspirin, and caffeine is commercially available in several different dose strengths and forms for its active components.


Q: Can Exidol be taken with antacids?

Official information indicates that the acetaminophen component of Exidol is generally considered safe to be used with common antacids like calcium carbonate. However, potential interactions with other components or specific antacids must be considered.


Q: Why do some people experience better results with Exidol than others?

Research exploring the use of this combination notes that studies do not determine whether an individual will respond similarly to the group patterns observed in controlled research settings. Individual physiological response is highly variable.


Q: Can Exidol affect liver function?

Yes. Exidol is contraindicated in severe hepatic failure, and its acetaminophen component has a documented risk of severe liver damage (hepatotoxicity). This risk is substantially increased when combined with alcohol or other acetaminophen products.


Q: Does Exidol have a Black Box Warning in the U.S. regulatory documents?

Yes. Medicines containing NSAIDs, such as Exidol, carry an Important Warning that highlights the documented risks of serious cardiovascular thrombotic events (like heart attack or stroke) and serious gastrointestinal adverse events (like bleeding or ulceration) that may occur.

How should Exidol be stored and disposed of?

How to Store and Dispose of Exidol?

The storage of Exidol must strictly follow regulatory mandates to ensure product stability and safety. The caplets must be kept at controlled room temperature, specifically below 25°C (77°F), and protected from excessive heat and moisture. The medicine must remain in its original, tightly closed container to shield it from light and maintain the stability of its components.

Handling and Disposal

All medicines, including Exidol, must be stored out of the sight and reach of children to prevent accidental ingestion. Disposal of expired or unused Exidol should be done through an authorized drug take-back program. If one is unavailable, follow the official protocol by mixing the medicine with an unappealing substance, placing it in a sealed bag, and discarding it in the household trash. Do not flush the medication down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Exidol found in:

A-Z Index: